BIOLINERX
BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.
BIOLINERX
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2003-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.biolinerx.com
Total Employee:
51+
Status:
Active
Contact:
+972 2-548-9100
Email Addresses:
[email protected]
Total Funding:
196.74 M USD
Technology used in webpage:
IPv6 YouTube COVID-19 Facebook Sharer New Relic Mobile Optimized Apple Whitelist FLoC Opt-Out FLoC Drupal
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-03-23 | Agalimmune | Agalimmune acquired by BiolineRx | 6 M USD |
Investors List
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - BiolineRx
Novartis
Novartis investment in Post-IPO Equity - BiolineRx
OrbiMed
OrbiMed investment in Post-IPO Equity - BiolineRx
Pitango Venture Capital
Pitango Venture Capital investment in Venture Round - BiolineRx
Giza Venture Capital
Giza Venture Capital investment in Venture Round - BiolineRx
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries investment in Venture Round - BiolineRx
Yehuda Zisapel
Yehuda Zisapel investment in Venture Round - BiolineRx
Star Ventures
Star Ventures investment in Venture Round - BiolineRx
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-16 | BioLineRx Announces Appointment of Commercial Strategy and Operations Veteran Holly W. May as Chief Commercial Officer |
Official Site Inspections
http://www.biolinerx.com Semrush global rank: 4.95 M Semrush visits lastest month: 1.72 K
- Host name: afa7f374f51cc8991.awsglobalaccelerator.com
- IP address: 15.197.167.90
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
